Rosuvastatin 20 mg + Clopidogrel 75 mg + Aspirin 75 mg is a comprehensive cardiovascular protection combination designed to reduce the risk of heart attack, stroke, and other atherosclerotic complications. This triple-action formulation combines lipid-lowering therapy with dual antiplatelet protection to provide effective management in patients with coronary artery disease, post-angioplasty status, and high cardiovascular risk. Rosuvastatin belongs to the statin class and works by lowering LDL cholesterol and triglycerides while increasing HDL cholesterol. Clopidogrel is an antiplatelet agent that prevents blood clot formation by inhibiting platelet aggregation. Aspirin acts as an antiplatelet and anti-inflammatory agent, reducing clot formation risk and improving blood flow. This combination is commonly prescribed for long-term secondary prevention in patients with established cardiovascular disease.
